The use of immunotoxins for cancer therapy
- 31 December 1993
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (11) , 1606-1609
- https://doi.org/10.1016/0959-8049(93)90306-z
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice.Journal of Clinical Investigation, 1992
- The crystal structure of diphtheria toxinNature, 1992
- Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusionBlood, 1992
- Recombinant Toxins for Cancer TreatmentScience, 1991
- A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxinNature, 1989
- Phase I Study of an Anti-Breast Cancer Immunotoxin by Continuous Infusion: Report of a Targeted Toxic Effect Not Predicted by Animal StudiesJNCI Journal of the National Cancer Institute, 1989
- Evaluation of four CD22 antibodies as ricin a chain‐containing immunotoxins for the in vivo therapy of human B‐cell leukemias and lymphomasInternational Journal of Cancer, 1988
- Diphtheria-related peptide hormone gene fusions: A molecular genetic approach to chimeric toxin developmentPublished by Springer Nature ,1988
- Functional domains of pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coliCell, 1987
- Immunotoxins: A New Approach to Cancer TherapyScience, 1983